Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus

Marianna Rachmiel*, Pnina Strauss, Nitzan Dror, Hadassa Benzaquen, Orit Horesh, Nave Tov, Naomi Weintrob, Zohar Landau, Michal Ben-Ami, Alon Haim, Moshe Phillip, Tzvi Bistritzer, Eli C. Lewis, Yael Lebenthal

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science